Skip to content

Interlock™ M001361750Recalls & reported problems

Boston Scientific Corporation · Fibered IDC™ Occlusion System · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729765097), received between Oct 6, 2021 and Oct 6, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Activation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Premature Activation1
  • Stretched1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 6, 2021Premature Activation; Stretched; Premature Activation; Stretched

    REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 16SEP2021. IT WAS REPORTED THAT THE COIL PREMATURELY DETACHED IN THE CATHETER. A VORTX DIAMOND 2/4MM X 4.1CM INTERLOCK COIL WAS SELECTED FOR USE. DURING THE PROCEDURE, IT WAS NOTED THAT THE COIL PREMATURELY DETACHED IN THE CATHETER. PER PHYSICIAN'S COMMENT, THERE WAS UNRAVELLING CAUSED BY THE DEVICE. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, DEVICE ANALYSIS REVEALED MISSING FIBER BUNDLES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12585019 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page